Loading insider details...
Beta
Latest Form 4 (Jul 30, 2026): Grant/Award of 185,798 YARW shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | Yarrow Bioscience, Inc. (YARW) | Grant/Award | 185,798 | n/a |
| Jul 24, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 22,516 | $20.2K |
| Jul 3, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,464 | $2.3K |
| Apr 2, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 4,007 | $2.4K |
| Jan 5, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 7,858 | $4.6K |
| Oct 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,420 | $1.1K |
| Jul 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,420 | $5.6K |
| Apr 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 8,399 | $13.3K |
| Jan 23, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 230,000 | n/a |
| Jan 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 4,675 | $15.7K |